Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
Clinical trial NCT07071246 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07071246
- Sponsor
- Tang-Du Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2027-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.